Analysis by ML models and methods confirmed the findings that the addition of both stromal FOXC1 and tumor pERK1‐2 to established factors of prognosis (NCCN‐IPI, cell of origin, and MYC/BCL2 double expression) improved C‐index. The gene discussed is BCL2; the disease is neoplasm.